Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals
- 7 May 2003
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 63 (5), 400-409
- https://doi.org/10.1034/j.1399-0004.2003.00067.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717–9T→C-D565G) and one nonsense mutation (E822X) in the CFTR geneHuman Genetics, 2001
- Fetal echogenic bowel: parameters to be considered in differential diagnosisUltrasound in Obstetrics & Gynecology, 2000
- The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American populationPrenatal Diagnosis, 1999
- Cystic fibrosis mutations and associated haplotypes in Bulgaria - a comparative population genetic studyHuman Genetics, 1997
- CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern FranceHuman Genetics, 1996
- PRENATAL DIAGNOSIS OF CYSTIC FIBROSIS IN A HIGHLY HETEROGENEOUS POPULATIONPrenatal Diagnosis, 1996
- Mutation analysis in 600 French cystic fibrosis patients.Journal of Medical Genetics, 1994
- Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracersHuman Molecular Genetics, 1993
- Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: Their incidence and clinical features of defined genotypesHuman Mutation, 1993
- Molecular characterization of cystic fibrosis: 16 Novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctionsGenomics, 1992